Clinical Translational Science Institute
“Translational science” or “translational research” is focused on accelerating the transformation of experimental treatment into applicable forms of patient care (bench-to-bedside) in areas including, but not limited to:
- Genetics / Genomics
- Drug and Device Development
- Preventative Medicine
- Community Based-Participatory Research
CTSA or CTSI?
The Clinical Translational Science Awards (CTSA) is the umbrella program that funds and oversees Clinical Translational Science Institutions (CTSI) across the country.
“SC CTSI” at USC
The Southern California CTSI is one of 60 institutions to receive funding from the NIH Clinical Translational Science Awards (CTSA) program.
About SC CTSI
- Education & Training
- Community Engaged Research
- Funding: In 2010 the “SC CTSI” became the recipient of a $56.8 million CTSA award. The SC CTSI has made some of that funding available through awards for research.
CTSI at Other Institutions
The USC CTSI is one in a network of institutions across the country who receive funding from the CTSA to promote interdisciplinary partnerships and research with clinical-translational potential.
- Institutions Receiving CTSA Funds
- Notable Institutions
CTSA – Clinical Translational Science Awards
- Foster high-risk/high-reward research
- Enable the development of transformative tools and methodologies
- Fill fundamental knowledge gaps
- Change academic culture to foster collaboration
CTSA Key Function Committees
- Biostatistics/Epidemiology/Research Design
- Clinical Research Ethics
- Clinical Research Management
- Clinical Services Core
- Community Engagement
- Comparative Effectiveness Research
- Education and Career Development
- Public-Private Partnerships
- Regulatory Knowledge